Atlas Trials

Phase I/IIa Study for PM1032 in the Treatment of Patients With Advanced Solid Tumors

Clinical trial NCT05839106 · UNKNOWN

Trial details

NCT number
NCT05839106
Sponsor
Biotheus Inc.
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced Tumor
Start date
2022-07-08
Primary completion
2025-04-10
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.